Synopsis
This report illustrates how Kable Market Research expects the top ICT spenders in Australia Pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, communications and consulting.
Scope
Identify the top ICT spenders in Australia Pharmaceutical industry.
Gain a view as to how each top spender in Australia Pharmaceutical industry allocates its ICT by IT function.
Get a detailed breakdown of estimated budget allocation of top spenders in Australia Pharmaceutical industry within each of the core areas of ICT spend (hardware, software, IT Services, telecommunications & consulting).
Summary
Why was the report written?
This report presents the output from Kable Market Research’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of survey and interview data Kable Market Research has conducted with ICT decision makers on their ICT spending, as well as the insight of our analyst team.
What makes this report unique and essential to read?
The predictions were formulated in November 2012 following a large survey of ICT decision makers. Estimated trends in ICT spending have been identified through to the end of 2013 following feedback from respondents on their forthcoming investment plans.
Reasons To Buy
NA
Table of Contents
1 Top-level ICT budget breakdowns
1.1 Introduction
2 Top ICT spenders
3 CSL Limited
3.1 Estimated ICT budget breakdown by function
3.2 Estimated external ICT budget allocation by core technology area
3.3 Detailed ICT budget allocations
3.3.1 Estimated hardware budget breakdown
3.3.2 Estimated software budget breakdown by technology
3.3.3 Estimated software budget breakdown by type
3.3.4 Estimated IT services budget breakdown
3.3.5 Estimated IT consulting services budget breakdown
3.3.6 Estimated telecommunications budget breakdown
4 Blackmores Limited
4.1 Estimated ICT budget breakdown by function
4.2 Estimated external ICT budget allocation by core technology area
4.3 Detailed ICT budget allocations
4.3.1 Estimated hardware budget breakdown
4.3.2 Estimated software budget breakdown by technology
4.3.3 Estimated software budget breakdown by type
4.3.4 Estimated IT services budget breakdown
4.3.5 Estimated IT consulting services budget breakdown
4.3.6 Estimated telecommunications budget breakdown
5 Ego Pharmaceuticals
5.1 Estimated ICT budget breakdown by function
5.2 Estimated external ICT budget allocation by core technology area
5.3 Detailed ICT budget allocations
5.3.1 Estimated hardware budget breakdown
5.3.2 Estimated software budget breakdown by technology
5.3.3 Estimated software budget breakdown by type
5.3.4 Estimated IT services budget breakdown
5.3.5 Estimated IT consulting services budget breakdown
5.3.6 Estimated telecommunications budget breakdown
6 Sirtex Medical Limited
6.1 Estimated ICT budget breakdown by function
6.2 Estimated external ICT budget allocation by core technology area
6.3 Detailed ICT budget allocations
6.3.1 Estimated hardware budget breakdown
6.3.2 Estimated software budget breakdown by technology
6.3.3 Estimated software budget breakdown by type
6.3.4 Estimated IT services budget breakdown
6.3.5 Estimated IT consulting services budget breakdown
6.3.6 Estimated telecommunications budget breakdown
7 Probiotec Limited
7.1 Estimated ICT budget breakdown by function
7.2 Estimated external ICT budget allocation by core technology area
7.3 Detailed ICT budget allocations
7.3.1 Estimated hardware budget breakdown
7.3.2 Estimated software budget breakdown by technology
7.3.3 Estimated software budget breakdown by type
7.3.4 Estimated IT services budget breakdown
7.3.5 Estimated IT consulting services budget breakdown
7.3.6 Estimated telecommunications budget breakdown
8 Mayne Pharma
8.1 Estimated ICT budget breakdown by function
8.2 Estimated external ICT budget allocation by core technology area
8.3 Detailed ICT budget allocations
8.3.1 Estimated hardware budget breakdown
8.3.2 Estimated software budget breakdown by technology
8.3.3 Estimated software budget breakdown by type
8.3.4 Estimated IT services budget breakdown
8.3.5 Estimated IT consulting services budget breakdown
8.3.6 Estimated telecommunications budget breakdown
9 Mesoblast Limited
9.1 Estimated ICT budget breakdown by function
9.2 Estimated external ICT budget allocation by core technology area
9.3 Detailed ICT budget allocations
9.3.1 Estimated hardware budget breakdown
9.3.2 Estimated software budget breakdown by technology
9.3.3 Estimated software budget breakdown by type
9.3.4 Estimated IT services budget breakdown
9.3.5 Estimated IT consulting services budget breakdown
9.3.6 Estimated telecommunications budget breakdown
10 Vita Life Sciences Limited
10.1 Estimated ICT budget breakdown by function
10.2 Estimated external ICT budget allocation by core technology area
10.3 Detailed ICT budget allocations
10.3.1 Estimated hardware budget breakdown
10.3.2 Estimated software budget breakdown by technology
10.3.3 Estimated software budget breakdown by type
10.3.4 Estimated IT services budget breakdown
10.3.5 Estimated IT consulting services budget breakdown
10.3.6 Estimated telecommunications budget breakdown
11 Universal Biosensors Inc.
11.1 Estimated ICT budget breakdown by function
11.2 Estimated external ICT budget allocation by core technology area
11.3 Detailed ICT budget allocations
11.3.1 Estimated hardware budget breakdown
11.3.2 Estimated software budget breakdown by technology
11.3.3 Estimated software budget breakdown by type
11.3.4 Estimated IT services budget breakdown
11.3.5 Estimated IT consulting services budget breakdown
11.3.6 Estimated telecommunications budget breakdown
12 Panbio Limited
12.1 Estimated ICT budget breakdown by function
12.2 Estimated external ICT budget allocation by core technology area
12.3 Detailed ICT budget allocations
12.3.1 Estimated hardware budget breakdown
12.3.2 Estimated software budget breakdown by technology
12.3.3 Estimated software budget breakdown by type
12.3.4 Estimated IT services budget breakdown
12.3.5 Estimated IT consulting services budget breakdown
12.3.6 Estimated telecommunications budget breakdown
13 Appendix
13.1 Definitions
13.2 Further reading
13.3 Contact the authors
List Of Tables
Table 1: Top ICT spenders in the Australian pharmaceutical industry
Table 2: CSL Limited will spend an estimated AUD 19m on its data centre
Table 3: CSL Limited will spend an estimated AUD 19m on hardware
Table 4: CSL Limited will spend an estimated AUD 4m on clients
Table 5: CSL Limited will spend an estimated AUD 3m on enterprise applications
Table 6: CSL Limited will spend an estimated AUD 6m on software licenses
Table 7: CSL Limited will spend an estimated AUD 3m on application development & integration
Table 8: CSL Limited will spend an estimated AUD 3m on systems planning & design
Table 9: CSL Limited will spend an estimated AUD 2m on fixed voice
Table 10: Blackmores Limited will spend an estimated AUD 2m on its data centre
Table 11: Blackmores Limited will spend an estimated AUD 3m on hardware
Table 12: Blackmores Limited will spend an estimated AUD 1m on clients
Table 13: Blackmores Limited will spend an estimated AUD 0.4m on enterprise applications
Table 14: Blackmores Limited will spend an estimated AUD 1m on software licenses
Table 15: Blackmores Limited will spend an estimated AUD 0.3m on application development & integration
Table 16: Blackmores Limited will spend an estimated AUD 0.4m on systems planning & design
Table 17: Blackmores Limited will spend an estimated AUD 0.3m on mobile voice
Table 18: Ego Pharmaceuticals will spend an estimated AUD 1m on its data centre
Table 19: Ego Pharmaceuticals will spend an estimated AUD 1m on hardware
Table 20: Ego Pharmaceuticals will spend an estimated AUD 0.2m on clients
Table 21: Ego Pharmaceuticals will spend an estimated AUD 0.1m on enterprise applications
Table 22: Ego Pharmaceuticals will spend an estimated AUD 0.3m on software licenses
Table 23: Ego Pharmaceuticals will spend an estimated AUD 0.1m on application development & integration
Table 24: Ego Pharmaceuticals will spend an estimated AUD 0.1m on systems planning & design
Table 25: Ego Pharmaceuticals will spend an estimated AUD 0.1m on fixed voice
Table 26: Sirtex Medical Limited will spend an estimated AUD 1m on its data centre
Table 27: Sirtex Medical Limited will spend an estimated AUD 1m on hardware
Table 28: Sirtex Medical Limited will spend an estimated AUD 0.2m on clients
Table 29: Sirtex Medical Limited will spend an estimated AUD 0.1m on enterprise applications
Table 30: Sirtex Medical Limited will spend an estimated AUD 0.3m on software licenses
Table 31: Sirtex Medical Limited will spend an estimated AUD 0.1m on application development & integration
Table 32: Sirtex Medical Limited will spend an estimated AUD 0.1m on systems planning & design
Table 33: Sirtex Medical Limited will spend an estimated AUD 0.1m on data
Table 34: Probiotec Limited will spend an estimated AUD 1m on its data centre
Table 35: Probiotec Limited will spend an estimated AUD 1m on hardware
Table 36: Probiotec Limited will spend an estimated AUD 0.2m on clients
Table 37: Probiotec Limited will spend an estimated AUD 0.1m on enterprise applications
Table 38: Probiotec Limited will spend an estimated AUD 0.2m on software vendors’ support costs/maintenance
Table 39: Probiotec Limited will spend an estimated AUD 0.1m on application development & integration
Table 40: Probiotec Limited will spend an estimated AUD 0.1m on systems planning & design
Table 41: Probiotec Limited will spend an estimated AUD 0.1m on fixed voice
Table 42: Mayne Pharma will spend an estimated AUD 0.5m on its data centre
Table 43: Mayne Pharma will spend an estimated AUD 1m on hardware
Table 44: Mayne Pharma will spend an estimated AUD 0.1m on clients
Table 45: Mayne Pharma will spend an estimated AUD 0.1m on enterprise applications
Table 46: Mayne Pharma will spend an estimated AUD 0.2m on software vendors’ support costs/maintenance
Table 47: Mayne Pharma will spend an estimated AUD 0.1m on application development & integration
Table 48: Mayne Pharma will spend an estimated AUD 0.1m on systems planning & design
Table 49: Mayne Pharma will spend an estimated AUD 0.1m on fixed voice
Table 50: Mesoblast Limited will spend an estimated AUD 0.3m on its data centre
Table 51: Mesoblast Limited will spend an estimated AUD 0.5m on hardware
Table 52: Mesoblast Limited will spend an estimated AUD 0.1m on clients
Table 53: Mesoblast Limited will spend an estimated AUD 0.1m on enterprise applications
Table 54: Mesoblast Limited will spend an estimated AUD 0.1m on software licenses
Table 55: Mesoblast Limited will spend an estimated AUD 0.05m on desktop services & user support
Table 56: Mesoblast Limited will spend an estimated AUD 0.04m on systems planning & design
Table 57: Mesoblast Limited will spend an estimated AUD 0.04m on fixed voice
Table 58: Vita Life Sciences Limited will spend an estimated AUD 0.3m on its data centre
Table 59: Vita Life Sciences Limited will spend an estimated AUD 0.4m on hardware
Table 60: Vita Life Sciences Limited will spend an estimated AUD 0.1m on clients
Table 61: Vita Life Sciences Limited will spend an estimated AUD 0.1m on enterprise applications
Table 62: Vita Life Sciences Limited will spend an estimated AUD 0.1m on software licenses
Table 63: Vita Life Sciences Limited will spend an estimated AUD 0.04m on desktop services & user support
Table 64: Vita Life Sciences Limited will spend an estimated AUD 0.04m on systems planning & design
Table 65: Vita Life Sciences Limited will spend an estimated AUD 0.04m on fixed voice
Table 66: Universal Biosensors Inc. will spend an estimated AUD 0.3m on its data centre
Table 67: Universal Biosensors Inc. will spend an estimated AUD 0.3m on hardware
Table 68: Universal Biosensors Inc. will spend an estimated AUD 0.1m on clients
Table 69: Universal Biosensors Inc. will spend an estimated AUD 0.1m on enterprise applications
Table 70: Universal Biosensors Inc. will spend an estimated AUD 0.1m on software licenses
Table 71: Universal Biosensors Inc. will spend an estimated AUD 0.03m on application development & integration
Table 72: Universal Biosensors Inc. will spend an estimated AUD 0.03m on systems planning & design
Table 73: Universal Biosensors Inc. will spend an estimated AUD 0.03m on fixed voice
Table 74: Panbio Limited will spend an estimated AUD 0.2m on its data centre
Table 75: Panbio Limited will spend an estimated AUD 0.3m on hardware
Table 76: Panbio Limited will spend an estimated AUD 0.1m on clients
Table 77: Panbio Limited will spend an estimated AUD 0.03m on information management
Table 78: Panbio Limited will spend an estimated AUD 0.1m on software licenses
Table 79: Panbio Limited will spend an estimated AUD 0.03m on application development & integration
Table 80: Panbio Limited will spend an estimated AUD 0.05m on training, education and other consulting
Table 81: Panbio Limited will spend an estimated AUD 0.03m on fixed voice
List Of Figures
Figure 1: Top ICT spenders in the Australian pharmaceutical industry
